AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
This Quarter Return
+10.65%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$204M
AUM Growth
+$204M
(+26%)
Cap. Flow
+$41.5M
Cap. Flow
% of AUM
20.33%
Top 10 Holdings %
Top 10 Hldgs %
55.9%
Holding
86
New
22
Increased
23
Reduced
8
Closed
16
Top Buys
| 1 |
BridgeBio Pharma
BBIO
|
$26M |
| 2 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$8.07M |
| 3 |
ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
|
$7.33M |
| 4 |
Aclaris Therapeutics
ACRS
|
$5.6M |
| 5 |
Travere Therapeutics
TVTX
|
$5.49M |
Top Sells
| 1 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$29.6M |
| 2 |
Curis
CRIS
|
$5.09M |
| 3 |
Immunovant
IMVT
|
$3.46M |
| 4 |
Sutro Biopharma
STRO
|
$2.73M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$2.36M |
Sector Composition
| 1 | Healthcare | 91.63% |
| 2 | Financials | 3.59% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-10,000
| Closed | -$2.36M |
|
|
VXRT
77
DELISTED
Vaxart
VXRT
| – | – |
0
| – | – |
|
|
MRTX
78
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-10,000
| Closed | -$2.2M |
|
|
SIOX
79
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| – | – |
-250,000
| Closed | -$695K |
|
|
RUBY
80
DELISTED
Rubius Therapeutics, Inc
RUBY
| – | – |
0
| – | – |
|
|
ATNX
81
DELISTED
Athenex, Inc. Common Stock
ATNX
| – | – |
-200,000
| Closed | -$2.21M |
|
|
RCOR
82
DELISTED
Renovacor, Inc.
RCOR
| – | – |
-75,000
| Closed | -$794K |
|
|
DRNA
83
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-40,000
| Closed | -$881K |
|
|
PAND
84
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| – | – |
-80,000
| Closed | -$1.19M |
|
|
EIDX
85
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| – | – |
-225,000
| Closed | -$29.6M |
|